{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:54:55Z","timestamp":1789750495339,"version":"4.0.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172823"],"award-info":[{"award-number":["82172823"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52201-z","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T06:02:43Z","timestamp":1725861763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["USP26 as a hepatitis B virus-induced deubiquitinase primes hepatocellular carcinogenesis by epigenetic remodeling"],"prefix":"10.1038","volume":"15","author":[{"given":"Mengru","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4393-7296","authenticated-orcid":false,"given":"Fan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-5987","authenticated-orcid":false,"given":"Pengyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1586-8710","authenticated-orcid":false,"given":"Peijing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"52201_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3322\/caac.21402","volume":"67","author":"F Islami","year":"2017","unstructured":"Islami, F. et al. Disparities in liver cancer occurrence in the United States by race\/ethnicity and state. CA Cancer J. Clin. 67, 273\u2013289 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"52201_CR2","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva, A. Hepatocellular Carcinoma. N. Engl. J. Med. 380, 1450\u20131462 (2019).","journal-title":"N. Engl. J. Med."},{"key":"52201_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/JHC.S307962","volume":"8","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y., Han, Q., Zhao, H. & Zhang, J. The Mechanisms of HBV-Induced Hepatocellular Carcinoma. J. Hepatocell. Carcinoma 8, 435\u2013450 (2021).","journal-title":"J. Hepatocell. Carcinoma"},{"key":"52201_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/brv.12457","volume":"94","author":"WY Lee","year":"2019","unstructured":"Lee, W. Y., Bachtiar, M., Choo, C. C. S. & Lee, C. G. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics. Biol. Rev. Camb. Philos. Soc. 94, 353\u2013367 (2019).","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"52201_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ng.2295","volume":"44","author":"WK Sung","year":"2012","unstructured":"Sung, W. K. et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet 44, 765\u2013769 (2012).","journal-title":"Nat. Genet"},{"key":"52201_CR6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ng.2291","volume":"44","author":"A Fujimoto","year":"2012","unstructured":"Fujimoto, A. et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet 44, 760\u2013764 (2012).","journal-title":"Nat. Genet"},{"key":"52201_CR7","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.cell.2019.10.038","volume":"179","author":"Q Gao","year":"2019","unstructured":"Gao, Q. et al. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. Cell 179, 1240 (2019).","journal-title":"Cell"},{"key":"52201_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nm.4275","volume":"23","author":"P Fisicaro","year":"2017","unstructured":"Fisicaro, P. et al. Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. Nat. Med. 23, 327\u2013336 (2017).","journal-title":"Nat. Med"},{"key":"52201_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ccr.2012.07.023","volume":"22","author":"P Yang","year":"2012","unstructured":"Yang, P. et al. TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 22, 291\u2013303 (2012).","journal-title":"Cancer Cell"},{"key":"52201_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12072-018-9919-1","volume":"13","author":"T Couri","year":"2019","unstructured":"Couri, T. & Pillai, A. Goals and targets for personalized therapy for HCC. Hepatol. Int 13, 125\u2013137 (2019).","journal-title":"Hepatol. Int"},{"key":"52201_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet, J. M. et al. Immunotherapies for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 19, 151\u2013172 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"52201_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo, M. et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 391, 1163\u20131173 (2018).","journal-title":"Lancet"},{"key":"52201_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","volume":"389","author":"J Bruix","year":"2017","unstructured":"Bruix, J. et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 389, 56\u201366 (2017).","journal-title":"Lancet"},{"key":"52201_CR14","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1080\/15548627.2022.2117893","volume":"19","author":"J Pan","year":"2023","unstructured":"Pan, J. et al. Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma. Autophagy 19, 1184\u20131198 (2023).","journal-title":"Autophagy"},{"key":"52201_CR15","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/S1470-2045(20)30156-X","volume":"21","author":"MS Lee","year":"2020","unstructured":"Lee, M. S. et al. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. Lancet Oncol. 21, 808\u2013820 (2020).","journal-title":"Lancet Oncol."},{"key":"52201_CR16","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn, R. S. et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N. Engl. J. Med. 382, 1894\u20131905 (2020).","journal-title":"N. Engl. J. Med."},{"key":"52201_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","volume":"23","author":"T Yau","year":"2022","unstructured":"Yau, T. et al. Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol. 23, 77\u201390 (2022).","journal-title":"Lancet Oncol."},{"key":"52201_CR18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/hep.32419","volume":"76","author":"S Suthen","year":"2022","unstructured":"Suthen, S. et al. Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC. Hepatology 76, 1329\u20131344 (2022).","journal-title":"Hepatology"},{"key":"52201_CR19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/gutjnl-2021-326620","volume":"72","author":"MJ Gonzalez-Rellan","year":"2023","unstructured":"Gonzalez-Rellan, M. J. et al. Hepatic p63 regulates glucose metabolism by repressing SIRT1. Gut 72, 472\u2013483 (2023).","journal-title":"Gut"},{"key":"52201_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36543-8","volume":"14","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Nicotine rebalances NAD(+) homeostasis and improves aging-related symptoms in male mice by enhancing NAMPT activity. Nat. Commun. 14, 900 (2023).","journal-title":"Nat. Commun."},{"key":"52201_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41589-022-01240-y","volume":"19","author":"X Zhu","year":"2023","unstructured":"Zhu, X. et al. SIRT1 deacetylates WEE1 and sensitizes cancer cells to WEE1 inhibition. Nat. Chem. Biol. 19, 585\u2013595 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"52201_CR22","doi-asserted-by":"publisher","first-page":"6754","DOI":"10.1093\/nar\/gkad504","volume":"51","author":"G Rasti","year":"2023","unstructured":"Rasti, G. et al. SIRT1 regulates DNA damage signaling through the PP4 phosphatase complex. Nucleic Acids Res. 51, 6754\u20136769 (2023).","journal-title":"Nucleic Acids Res."},{"key":"52201_CR23","doi-asserted-by":"publisher","unstructured":"Zhao, E. et al. The Roles of Sirtuin Family Proteins in Cancer Progression. Cancers (Basel) 11, https:\/\/doi.org\/10.3390\/cancers11121949 (2019).","DOI":"10.3390\/cancers11121949"},{"key":"52201_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.751516","volume":"8","author":"F Kong","year":"2021","unstructured":"Kong, F. et al. Sirtuins as Potential Therapeutic Targets for Hepatitis B Virus Infection. Front Med (Lausanne) 8, 751516 (2021).","journal-title":"Front Med (Lausanne)"},{"key":"52201_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41580-022-00543-1","volume":"24","author":"I Dikic","year":"2023","unstructured":"Dikic, I. & Schulman, B. A. An expanded lexicon for the ubiquitin code. Nat. Rev. Mol. Cell Biol. 24, 273\u2013287 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"52201_CR26","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/s41556-020-00579-5","volume":"22","author":"C Xu","year":"2020","unstructured":"Xu, C. et al. SIRT1 is downregulated by autophagy in senescence and ageing. Nat. Cell Biol. 22, 1170\u20131179 (2020).","journal-title":"Nat. Cell Biol."},{"key":"52201_CR27","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1038\/s41388-020-1298-0","volume":"39","author":"L Yu","year":"2020","unstructured":"Yu, L. et al. Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis. Oncogene 39, 4450\u20134464 (2020).","journal-title":"Oncogene"},{"key":"52201_CR28","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/s12276-023-01012-1","volume":"55","author":"SH Lee","year":"2023","unstructured":"Lee, S. H. et al. SIRT1 ubiquitination is regulated by opposing activities of APC\/C-Cdh1 and AROS during stress-induced premature senescence. Exp. Mol. Med. 55, 1232\u20131246 (2023).","journal-title":"Exp. Mol. Med."},{"key":"52201_CR29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ncb3013","volume":"16","author":"P Zhang","year":"2014","unstructured":"Zhang, P. et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat. Cell Biol. 16, 864\u2013875 (2014).","journal-title":"Nat. Cell Biol."},{"key":"52201_CR30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.celrep.2018.03.078","volume":"23","author":"P Zhang","year":"2018","unstructured":"Zhang, P. et al. ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer. Cell Rep. 23, 823\u2013837 (2018).","journal-title":"Cell Rep."},{"key":"52201_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.molcel.2012.03.024","volume":"46","author":"Z Lin","year":"2012","unstructured":"Lin, Z. et al. USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. Mol. Cell 46, 484\u2013494 (2012).","journal-title":"Mol. Cell"},{"key":"52201_CR32","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/j.drudis.2022.06.009","volume":"27","author":"F Ge","year":"2022","unstructured":"Ge, F. et al. Deubiquitinating enzymes: Promising targets for drug resistance. Drug Discov. Today 27, 2603\u20132613 (2022).","journal-title":"Drug Discov. Today"},{"key":"52201_CR33","doi-asserted-by":"publisher","unstructured":"Huang, S. et al. The deubiquitinase ZRANB1 is an E3 ubiquitin ligase for SLC7A11 and regulates ferroptotic resistance. J. Cell Biol. 222, https:\/\/doi.org\/10.1083\/jcb.202212072 (2023).","DOI":"10.1083\/jcb.202212072"},{"key":"52201_CR34","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106864","volume":"40","author":"C Liu","year":"2021","unstructured":"Liu, C. et al. Paternal USP26 mutations raise Klinefelter syndrome risk in the offspring of mice and humans. EMBO J. 40, e106864 (2021).","journal-title":"EMBO J."},{"key":"52201_CR35","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","volume":"184","author":"X Chen","year":"2014","unstructured":"Chen, X. & Calvisi, D. F. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am. J. Pathol. 184, 912\u2013923 (2014).","journal-title":"Am. J. Pathol."},{"key":"52201_CR36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","volume":"147","author":"J Tao","year":"2014","unstructured":"Tao, J. et al. Activation of beta-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Gastroenterology 147, 690\u2013701 (2014).","journal-title":"Gastroenterology"},{"key":"52201_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue, R. et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature 612, 141\u2013147 (2022).","journal-title":"Nature"},{"key":"52201_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn5683","volume":"8","author":"M Tang","year":"2022","unstructured":"Tang, M. et al. Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes. Sci. Adv. 8, eabn5683 (2022).","journal-title":"Sci. Adv."},{"key":"52201_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbrc.2016.10.135","volume":"482","author":"S Lahav-Baratz","year":"2017","unstructured":"Lahav-Baratz, S., Kravtsova-Ivantsiv, Y., Golan, S. & Ciechanover, A. The testis-specific USP26 is a deubiquitinating enzyme of the ubiquitin ligase Mdm2. Biochem Biophys. Res Commun. 482, 106\u2013111 (2017).","journal-title":"Biochem Biophys. Res Commun."},{"key":"52201_CR40","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1083\/jcb.201902074","volume":"218","author":"L Song","year":"2019","unstructured":"Song, L. & Luo, Z. Q. Post-translational regulation of ubiquitin signaling. J. Cell Biol. 218, 1776\u20131786 (2019).","journal-title":"J. Cell Biol."},{"key":"52201_CR41","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/hep.31222","volume":"72","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. SIRT1 Regulates N(6) -Methyladenosine RNA Modification in Hepatocarcinogenesis by Inducing RANBP2-Dependent FTO SUMOylation. Hepatology 72, 2029\u20132050 (2020).","journal-title":"Hepatology"},{"key":"52201_CR42","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1038\/s41388-021-01993-1","volume":"40","author":"P Qiu","year":"2021","unstructured":"Qiu, P. et al. Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice. Oncogene 40, 6023\u20136033 (2021).","journal-title":"Oncogene"},{"key":"52201_CR43","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/s42255-021-00498-1","volume":"3","author":"DC Levine","year":"2021","unstructured":"Levine, D. C. et al. NADH inhibition of SIRT1 links energy state to transcription during time-restricted feeding. Nat. Metab. 3, 1621\u20131632 (2021).","journal-title":"Nat. Metab."},{"key":"52201_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/CIRCRESAHA.111.243592","volume":"109","author":"S Zhou","year":"2011","unstructured":"Zhou, S. et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ. Res. 109, 639\u2013648 (2011).","journal-title":"Circ. Res."},{"key":"52201_CR45","doi-asserted-by":"publisher","first-page":"27097","DOI":"10.1074\/jbc.273.42.27097","volume":"273","author":"Y Lin","year":"1998","unstructured":"Lin, Y. et al. The hepatitis B virus X protein is a co-activator of activated transcription that modulates the transcription machinery and distal binding activators. J. Biol. Chem. 273, 27097\u201327103 (1998).","journal-title":"J. Biol. Chem."},{"key":"52201_CR46","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2006.08.043","volume":"131","author":"G Randall","year":"2006","unstructured":"Randall, G. et al. Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology 131, 1584\u20131591 (2006).","journal-title":"Gastroenterology"},{"key":"52201_CR47","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/nm1133","volume":"10","author":"KJ Ritchie","year":"2004","unstructured":"Ritchie, K. J. et al. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat. Med. 10, 1374\u20131378 (2004).","journal-title":"Nat. Med."},{"key":"52201_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep40246","volume":"7","author":"ZJ Su","year":"2017","unstructured":"Su, Z. J. et al. Deubiquitylation of hepatitis B virus X protein (HBx) by ubiquitin-specific peptidase 15 (USP15) increases HBx stability and its transactivation activity. Sci. Rep. 7, 40246 (2017).","journal-title":"Sci. Rep."},{"key":"52201_CR49","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson, G., Eichhorn, P. J. A. & Komander, D. Deubiquitinases in cancer. Nat. Rev. Cancer 23, 842\u2013862 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"52201_CR50","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/s41556-019-0409-z","volume":"21","author":"SM Shen","year":"2019","unstructured":"Shen, S. M. et al. PTENalpha and PTENbeta promote carcinogenesis through WDR5 and H3K4 trimethylation. Nat. Cell Biol. 21, 1436\u20131448 (2019).","journal-title":"Nat. Cell Biol."},{"key":"52201_CR51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nature11114","volume":"486","author":"PA Perez-Mancera","year":"2012","unstructured":"Perez-Mancera, P. A. et al. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486, 266\u2013270 (2012).","journal-title":"Nature"},{"key":"52201_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29846-9","volume":"13","author":"Z Ning","year":"2022","unstructured":"Ning, Z. et al. USP22 regulates lipidome accumulation by stabilizing PPARgamma in hepatocellular carcinoma. Nat. Commun. 13, 2187 (2022).","journal-title":"Nat. Commun."},{"key":"52201_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35469-x","volume":"13","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. PRDM1\/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nat. Commun. 13, 7677 (2022).","journal-title":"Nat. Commun."},{"key":"52201_CR54","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2217\/epi.14.22","volume":"6","author":"L Wang","year":"2014","unstructured":"Wang, L. & Dent, S. Y. Functions of SAGA in development and disease. Epigenomics 6, 329\u2013339 (2014).","journal-title":"Epigenomics"},{"key":"52201_CR55","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.1073\/pnas.0908365106","volume":"106","author":"L Belloni","year":"2009","unstructured":"Belloni, L. et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc. Natl. Acad. Sci. USA 106, 19975\u201319979 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"52201_CR56","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1128\/MCB.00205-13","volume":"33","author":"Y Tian","year":"2013","unstructured":"Tian, Y., Yang, W., Song, J., Wu, Y. & Ni, B. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol. Cell Biol. 33, 2810\u20132816 (2013).","journal-title":"Mol. Cell Biol."},{"key":"52201_CR57","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1245\/s10434-011-2159-4","volume":"19","author":"HC Chen","year":"2012","unstructured":"Chen, H. C., Jeng, Y. M., Yuan, R. H., Hsu, H. C. & Chen, Y. L. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis. Ann. Surg. Oncol. 19, 2011\u20132019 (2012).","journal-title":"Ann. Surg. Oncol."},{"key":"52201_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831168","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Regulation of SIRT1 and Its Roles in Inflammation. Front Immunol. 13, 831168 (2022).","journal-title":"Front Immunol."},{"key":"52201_CR59","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.7150\/ijms.43491","volume":"17","author":"Q Wang","year":"2020","unstructured":"Wang, Q., Cheng, S. T. & Chen, J. HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma Tumorigenesis. Int J. Med Sci. 17, 1783\u20131794 (2020).","journal-title":"Int J. Med Sci."},{"key":"52201_CR60","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1080\/14756366.2020.1758691","volume":"35","author":"S Broussy","year":"2020","unstructured":"Broussy, S., Laaroussi, H. & Vidal, M. Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat). J. Enzym. Inhib. Med Chem. 35, 1124\u20131136 (2020).","journal-title":"J. Enzym. Inhib. Med Chem."},{"key":"52201_CR61","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/biolre\/ioy258","volume":"100","author":"H Tian","year":"2019","unstructured":"Tian, H. et al. Disruption of ubiquitin specific protease 26 gene causes male subfertility associated with spermatogenesis defects in mice. dagger Biol. Reprod. 100, 1118\u20131128 (2019).","journal-title":"dagger Biol. Reprod."},{"key":"52201_CR62","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1158\/0008-5472.CAN-20-3453","volume":"81","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Hepatitis B-Induced IL8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation. Cancer Res. 81, 2386\u20132398 (2021).","journal-title":"Cancer Res."},{"key":"52201_CR63","doi-asserted-by":"publisher","first-page":"17059","DOI":"10.1073\/pnas.0502974102","volume":"102","author":"CM Carlson","year":"2005","unstructured":"Carlson, C. M., Frandsen, J. L., Kirchhof, N., McIvor, R. S. & Largaespada, D. A. Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse. Proc. Natl Acad. Sci. USA 102, 17059\u201317064 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52201-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52201-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52201-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T07:05:41Z","timestamp":1725865541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52201-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52201"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52201-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7856"}}